Clinical Trials

    A Phase 2a, Double-Blind, Randomized, Active Controlled, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Bezafibrate Administered in Combination with Obeticholic Acid in Subjects with Primary Biliary Cholangitis

    Investigator: David Victor

    Study Coordinator: Beatriz Efron

    Status: Open Not Enrolling

    ClinicalTrials.gov Number: NCT05239468

    Phone: 713.363.8890

    Protocol Number: PRO00032779

    Description


    Study to determine the effect of the investigational drug bezafibrate (BZF) alone and in combination with the investigational drug obeticholic acid (also known as OCA) in patients with Primary Biliary Cholangitis (also known as PBC).